Europe — EMA
Ngenla (Somatrogon)
GNH USA supplies Ngenla (Somatrogon), a growth hormone analog for treating growth hormone deficiency in children. Request a quote for global supply today.
Request sourcing
What is Somatrogon?
Somatrogon, the active ingredient in Ngenla, is a growth hormone analog presented as an injectable solution for subcutaneous use. It treats growth hormone deficiency in children, helping to promote linear growth and improve height outcomes.
GNH USA supplies Ngenla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Somatrogon used for?
Somatrogon is used in pediatric growth disorders that respond to growth hormone therapy. - Growth hormone deficiency in children: promotes linear growth and increases height velocity. - Idiopathic short stature in children: helps achieve normal growth patterns. - Growth failure associated with chronic kidney disease in pediatric patients: supports growth development.
What are the side effects of Somatrogon?
Somatrogon may cause a range of adverse reactions, most of which are mild and transient.
Common Side Effects: - Injection site pain or erythema - Headache - Nausea - Peripheral edema - Arthralgia - Fatigue
Serious or Rare Side Effects: - Intracranial hypertension - Slipped epiphysis (growth plate fracture) - Severe allergic reactions (anaphylaxis, urticaria) - Abnormal glucose metabolism or diabetes mellitus - Tumor recurrence or progression - Pancreatitis
What precautions apply to Somatrogon?
Before initiating therapy, clinicians should consider several safety measures. - Dose titration: adjust based on IGF‑1 levels and growth response. - Monitoring: regular assessment of growth parameters, IGF‑1, glucose, and thyroid function. - Contraindications: known hypersensitivity to somatrogon or any excipients. - Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. - Long‑term therapy: monitor for scoliosis progression and intracranial pressure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Somatrogon interact with?
Somatrogon can interact with several drug classes, requiring careful management.
Major Interactions (Avoid): - Glucocorticoids: may antagonize growth‑hormone effects. - Insulin or oral hypoglycemics: may need dose adjustment due to altered glucose metabolism. - Estrogen therapy: can excessively raise IGF‑1 levels.
Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: monitor thyroid function as GH can increase conversion. - Vitamin D or calcium supplements: watch for hypercalcemia. - Other peptide hormones (e.g., IGF‑1 therapy): assess for additive growth effects.
